VAXX Company Profile and Key Details
Vaxxinity, Inc.
VAXX Stock Price Chart
Stock Price Today
Vaxxinity, Inc. (VAXX) stock remained unchanged at $0.00 a share on NASDAQ. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
Company Information
| Employees | 57 |
| Beta | 1.07 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Vaxxinity, Inc. (NASDAQ: VAXX) stock price is $0.00 in the last trading session. During the trading session, VAXX stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in VAXX stock occurred in the recent session was 0% while the dollar amount for the price change in VAXX stock was -.
The NASDAQ listed VAXX is part of Biotechnology industry that operates in the broader Healthcare sector. Vaxxinity, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Ulo Palm M.D., Ph.D.
Chief Medical Officer
Mr. Jason Pesile CPA, M.B.A.
Senior Vice President of Fin. & Accounting
Mr. Jon Harrison
Chief Gov. Officer
Mr. Mark Joinnides
Chief of Staff
Ms. Amy B. Fix M.B.A., M.S., R.A.C.
Chief Regulatory Officer
Dr. Jean-Cosme Dodart Ph.D.
Senior Vice President of Preclinical R&D
Mr. Rene Paula Molina J.D.
Gen. Counsel & Sec.
Mr. Jason Pesile C.P.A., M.B.A.
Senior Vice President of Fin. & Accounting
Mr. Louis Garfield Reese IV
Co-Founder & Executive Chairman
Mr. Dwayne Soisson
Vice President of Operations
Mr. Benjamin Matone
Vice President of Investor Relations
Mr. Rene Paula Molina
Gen. Counsel & Sec.
Ms. Mei Mei Hu J.D.
Chief Executive Officer & Director
VAXX's closing price is 400% higher than its 52-week low of $0.00 where as its distance from 52-week high of $1.05 is -99.95%.
Number of VAXX employees currently stands at 57.
Official Website of VAXX is: https://www.vaxxinity.com
VAXX could be contacted at phone 254 244 5739 and can also be accessed through its website. VAXX operates from 1717 Main Street, Dallas, TX 75201, United States.
VAXX stock volume for the day was 100 shares. The average number of VAXX shares traded daily for last 3 months was 28.9K.
The market value of VAXX currently stands at $63.39K with its latest stock price at $0.00 and 126.79M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com